companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2020

CVR: 38231170

Source: annual report 2020, Danish Business Authority

01/04/2019 – 31/03/2020

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 838,894 and a net result of DKK -1,582,107 compared with DKK -1,145,346 the year before. That is an increase of 183.3% compared with the year before. Equity in the 2020 report amounted to DKK 10,128,327. The solvency ratio was 41.7%. The company had 2 employees in the financial year.

Gross Profit
DKK 838,894
Profit/Loss
DKK -1,582,107
Equity
DKK 10,128,327
Total Assets
DKK 24,309,356
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-839K-1.6M10.1M2
2019-296K-1.1M11.7M-
2018-485K-892K8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Hoba Therapeutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Torsten Meldgaard Madsen joins Hoba Therapeutics ApS as adm. dir.Jul 1, 2020

As of July 1, 2020, Torsten Meldgaard Madsen is registered as adm. dir. of Hoba Therapeutics ApS.

Kenneth Ahrend Petersen steps down as adm. dir. of Hoba Therapeutics ApSJul 1, 2020

As of July 1, 2020, Kenneth Ahrend Petersen has stepped down as adm. dir. of Hoba Therapeutics ApS.

Thor Jespersen joins the board of Hoba Therapeutics ApSJan 31, 2020

As of January 31, 2020, Thor Jespersen has joined the board of directors of Hoba Therapeutics ApS.

Steen Palle Petersen leaves the board of Hoba Therapeutics ApSJan 31, 2020

As of January 31, 2020, Steen Palle Petersen has left the board of directors of Hoba Therapeutics ApS.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority